Achilles Therapeutics Limited

📍 Stevenage, United Kingdom🗓 Founded 2016👥 80 employees
Biotechnology🌐 achillestx.com
Website LinkedIn
Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. The therapies will target truncal (also known as clonal) tumour neo-antigens, unique flags to the immune system present on the surface of every cancer cell. These truncal neo-antigens are created early in the cancer’s evolution and present on all cancer cells in an individual patient’s tumour but not on healthy cells, so could allow scientists to target and destroy tumours without harming healthy tissues. Achilles Therapeutics brings together four scientific Founders with world leading expertise in the understanding of cancer evolution, bioinformatics and the development of immunotherapies.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Achilles Therapeutics Limited founded?
Achilles Therapeutics Limited was founded in 2016.
What industry is Achilles Therapeutics Limited in?
Achilles Therapeutics Limited operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Achilles Therapeutics Limited based?
Achilles Therapeutics Limited is headquartered in Stevenage, United Kingdom.